• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fas反击诱导人结直肠癌肿瘤浸润淋巴细胞凋亡的频率及其与预后的相关性

Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.

作者信息

Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T

机构信息

Department of Surgery II, Nagasaki University School of Medicine, Japan.

出版信息

Clin Cancer Res. 2000 Sep;6(9):3560-4.

PMID:10999744
Abstract

We investigated apoptosis in tumor-infiltrating lymphocytes (TILs) obtained from 41 colorectal carcinomas by in situ nick translation (ISNT). When the ISNT labeling index (LI) was determined as the number of positive nuclei per 1000 nuclei of TIL in tissue sections, the median LI was 12.0 (range, 2-30). The ISNT LI of colorectal carcinoma with lymph node metastasis was higher than that of colorectal carcinoma without metastasis. The cases with a high LI of 212.0 had a significantly poorer prognosis than those with a low LI. We also confirmed immunohistochemically that a part of the TILs expressed Fas using the sections adjacent to what contained abundant ISNT-positive TILs. Moreover, Fas ligand (FasL) expression was detected on the cell surface as well as the cytoplasm of colorectal cancer cells in 61% of cases. Apoptosis in TILs was consistently seen more frequently in FasL-positive cases than in FasL-negative ones. These findings indicate that the FasL expressed in colorectal carcinoma cells may kill the Fas-positive immune effective TILs by means of a Fas-FasL system termed Fas counterattack. This tumor immune evasion induced by FasL may therefore affect the malignant potential of human colorectal carcinoma.

摘要

我们通过原位缺口平移法(ISNT)研究了从41例结直肠癌中获取的肿瘤浸润淋巴细胞(TIL)的凋亡情况。当将ISNT标记指数(LI)确定为组织切片中每1000个TIL细胞核中的阳性细胞核数量时,LI中位数为12.0(范围为2 - 30)。有淋巴结转移的结直肠癌的ISNT LI高于无转移的结直肠癌。LI≥212.0的病例预后明显比LI低的病例差。我们还通过免疫组织化学方法,利用含有大量ISNT阳性TIL的切片相邻的切片证实了部分TIL表达Fas。此外,在61%的病例中,在结肠癌细胞的细胞表面以及细胞质中检测到Fas配体(FasL)表达。FasL阳性病例中TIL的凋亡始终比FasL阴性病例更频繁地出现。这些发现表明,结肠癌细胞中表达的FasL可能通过一种称为Fas反击的Fas - FasL系统杀死Fas阳性的免疫效应TIL。因此这种由FasL诱导的肿瘤免疫逃逸可能会影响人类结直肠癌的恶性潜能。

相似文献

1
Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.Fas反击诱导人结直肠癌肿瘤浸润淋巴细胞凋亡的频率及其与预后的相关性
Clin Cancer Res. 2000 Sep;6(9):3560-4.
2
Fas-related apoptosis in gastric adenocarcinoma.胃腺癌中与Fas相关的细胞凋亡
Oncol Rep. 2003 Jan-Feb;10(1):57-63.
3
The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.Fas在体内的反击:人食管癌中与Fas配体表达相关的肿瘤浸润淋巴细胞的凋亡性耗竭。
J Immunol. 1998 Jun 1;160(11):5669-75.
4
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.根据微卫星不稳定性状态分层的结直肠癌中Fas配体与肿瘤反击
J Pathol. 2003 Sep;201(1):46-54. doi: 10.1002/path.1406.
5
Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.Fas介导的人恶性黑色素瘤中黑色素瘤细胞和浸润淋巴细胞的凋亡
Mod Pathol. 2002 Apr;15(4):387-96. doi: 10.1038/modpathol.3880535.
6
The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.“Fas反击”并非微卫星高度不稳定的结直肠癌中肿瘤免疫逃逸的主动模式。
Hum Pathol. 2008 Feb;39(2):243-50. doi: 10.1016/j.humpath.2007.06.010. Epub 2007 Oct 24.
7
Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.口腔癌患者循环及肿瘤浸润淋巴细胞的信号异常、凋亡及增殖减少。
Clin Cancer Res. 2002 Oct;8(10):3137-45.
8
Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.Fas和Fas配体表达在人食管癌中的预后意义
Clin Cancer Res. 1999 Sep;5(9):2464-9.
9
Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo.Fas标记状态与肾细胞癌在体内的凋亡无关。
Anticancer Res. 2001 Sep-Oct;21(5):3193-7.
10
Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.肝内胆管癌早期阶段Fas配体上调,进展期阶段Fas下调,这反映了其对免疫监视的逃避。
Hepatology. 2000 Oct;32(4 Pt 1):761-9. doi: 10.1053/jhep.2000.18192.

引用本文的文献

1
RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylation.RCAS1 通过减少 p38 磷酸化来增加鼠成纤维细胞的细胞形态变化。
Mol Med Rep. 2023 Mar;27(3). doi: 10.3892/mmr.2023.12949. Epub 2023 Feb 3.
2
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.异体癌细胞治疗的进展和使用 iPSC 技术和基因编辑的“现成”T 细胞治疗的未来展望。
Cells. 2022 Jan 13;11(2):269. doi: 10.3390/cells11020269.
3
CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
CDCA3 是一种与肝癌免疫浸润相关的新型预后生物标志物。
Biomed Res Int. 2021 Jan 29;2021:6622437. doi: 10.1155/2021/6622437. eCollection 2021.
4
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3.胰腺神经内分泌肿瘤 3 级的候选蛋白生物标志物。
Sci Rep. 2020 Jun 30;10(1):10639. doi: 10.1038/s41598-020-67670-7.
5
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.SIRT7是一种与腔面型乳腺癌免疫浸润相关的预后生物标志物。
Front Oncol. 2020 May 12;10:621. doi: 10.3389/fonc.2020.00621. eCollection 2020.
6
Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.维甲酸吗啉酰胺(RAMA)通过EP1受体抑制结肠癌细胞中Fas配体的表达。
Tumour Biol. 2016 Jan;37(1):323-9. doi: 10.1007/s13277-015-3798-z. Epub 2015 Jul 27.
7
FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.中国南方食管癌FasL基因-844T/C突变及其临床意义。
Sci Rep. 2014 Jan 29;4:3866. doi: 10.1038/srep03866.
8
Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.促肾上腺皮质激素释放激素(CRH)在人宫颈癌细胞(HeLa)中表达,并上调Fas配体的表达。
Tumour Biol. 2013 Feb;34(1):125-30. doi: 10.1007/s13277-012-0519-8. Epub 2012 Oct 18.
9
Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.卵巢上皮性肿瘤可能用于免疫逃逸的武器:一项免疫组织化学相关性研究。
Pathol Oncol Res. 2012 Apr;18(2):509-18. doi: 10.1007/s12253-011-9474-8. Epub 2011 Dec 8.
10
The immunoregulatory mechanisms of carcinoma for its survival and development.肿瘤的免疫调控机制促进其生存和发展。
J Exp Clin Cancer Res. 2011 Jan 21;30(1):12. doi: 10.1186/1756-9966-30-12.